Glycorex Transplantation AB (publ) (FRA:O33)

Germany · Delayed Price · Currency is EUR

0.1165

+0.0035 (3.10%)

Last updated: Oct 23, 2026, 9:43 PM CEST

Market Cap	10.75M -18.7%
Revenue (ttm)	3.11M -8.9%
Net Income	-1.15M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Open	0.1330
Previous Close	0.1130
Day's Range	0.1165 - 0.1330
52-Week Range	0.0206 - 0.2140
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2026

About FRA:O33

Glycorex Transplantation AB (publ), a medical technology company, research, develops, manufactures, markets, and sells products in the field of organ transplantation or related areas. It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood. The company’s principal product is Glycosorb-ABO, which enables blood group incompatible kidney transplantation and is also used to enable heart, liver, lung, and stem cell transplantation procedures. It serves in the United Kingdom, Australia, Scandi...

Industry Surgical and Medical Instruments and Apparatus

Founded 1995

Employees 20

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol O33